Elevated pulse rate in non-sleepy OSA heart patients may lead to serious cardiac events
COVID-19 monoclonal antibodies reduce risk of hospitalization and death
18 May 2021Portable, affordable, accurate, fast: Team invents new COVID-19 test
18 May 2021Elevated pulse rate in non-sleepy OSA heart patients may lead to serious cardiac events
Some patients with coronary artery disease and non-sleepy obstructive sleep apnea (OSA) may be protected against serious cardiac events by CPAP therapy, according to research presented at the ATS 2021 International Conference.
